<!DOCTYPE html>
<html><head><style>table, th, td {border: 1px solid black;border-collapse: collapse;}</style></head>
<table colsep="0" frame="topbot" id="t0015" trsep="0" xmlns="http://www.elsevier.com/xml/common/cals/dtd">
<label>
        Table 3
       </label>
<caption id="ca0020">
<simple-para id="sp0040" view="all">
         Treatment guidelines incorporating DL
         <inf loc="post">
          CO
         </inf>
         or splenomegaly reduction as clinically significant outcomes.
        </simple-para>
</caption>

<tgroup cols="4">
<colspec colname="col1"/>
<colspec colname="col2"/>
<colspec colname="col3"/>
<colspec colname="col4"/>
<thead>
<tr trsep="1" valign="top">
<td colname="col1" xmlns="http://www.elsevier.com/xml/common/dtd">
           Disease
          </td>
<td colname="col2" xmlns="http://www.elsevier.com/xml/common/dtd">
           Outcome
          </td>
<td colname="col3" xmlns="http://www.elsevier.com/xml/common/dtd">
           Guideline
          </td>
<td colname="col4" xmlns="http://www.elsevier.com/xml/common/dtd">
           Reference
          </td>
</tr>
</thead>
<tbody>
<tr>
<td colname="col1" xmlns="http://www.elsevier.com/xml/common/dtd">
           Gaucher disease
          </td>
<td colname="col2" xmlns="http://www.elsevier.com/xml/common/dtd">
           Splenomegaly
          </td>
<td colname="col3" xmlns="http://www.elsevier.com/xml/common/dtd">
<list id="l0005">
<list-item id="li0005">
<label>
              •
             </label>
<para id="p0005" view="all">
              Spleen volume should be expressed as multiples of normal with a treatment goal of 2–8 times reduction of normal and assessments at different time points up to 5 years
             </para>
</list-item>
</list>
</td>
<td colname="col4" xmlns="http://www.elsevier.com/xml/common/dtd">
<list id="l0010">
<list-item id="li0010">
<label>
              •
             </label>
<para id="p0010" view="all">
              European Working Group on Gaucher Disease [
              
              ,
              
              ]
             </para>
</list-item>
<list-item id="li0015">
<label>
              •
             </label>
<para id="p0015" view="all">
              US Food and Drug Administration [
              
              ]
             </para>
</list-item>
<list-item id="li0020">
<label>
              •
             </label>
<para id="p0020" view="all">
              European Medical Association [
              
              ]
             </para>
</list-item>
</list>
</td>
</tr>
<tr>
<td colname="col1" xmlns="http://www.elsevier.com/xml/common/dtd">
           Myelofibrosis
          </td>
<td colname="col2" xmlns="http://www.elsevier.com/xml/common/dtd">
           Splenomegaly
          </td>
<td colname="col3" xmlns="http://www.elsevier.com/xml/common/dtd">
<list id="l0015">
<list-item id="li0025">
<label>
              •
             </label>
<para id="p0025" view="all">
              Reduction of ≥35% in spleen volume as assessed by MRI or CT is indicative of response to treatment
             </para>
</list-item>
</list>
</td>
<td colname="col4" xmlns="http://www.elsevier.com/xml/common/dtd">
<list id="l0020">
<list-item id="li0030">
<label>
              •
             </label>
<para id="p0030" view="all">
              WHO International Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT) and European LeukemiaNet consensus report [
              
              ]
             </para>
</list-item>
</list>
</td>
</tr>
<tr>
<td colname="col1" xmlns="http://www.elsevier.com/xml/common/dtd">
           Idiopathic pulmonary fibrosis
          </td>
<td colname="col2" xmlns="http://www.elsevier.com/xml/common/dtd">
           DL
           <inf loc="post">
            CO
           </inf>
</td>
<td colname="col3" xmlns="http://www.elsevier.com/xml/common/dtd">
<list id="l0025">
<list-item id="li0035">
<label>
              •
             </label>
<para id="p0035" view="all">
              A decrease of &gt;15% DL
              <inf loc="post">
               CO
              </inf>
              in absolute values is associated with disease worsening/increased risk of mortality
             </para>
</list-item>
</list>
</td>
<td colname="col4" xmlns="http://www.elsevier.com/xml/common/dtd">
<list id="l0030">
<list-item id="li0040">
<label>
              •
             </label>
<para id="p0040" view="all">
              2017 Spanish IPF guidelines [
              
              ,
              
              ]
             </para>
</list-item>
<list-item id="li0045">
<label>
              •
             </label>
<para id="p0045" view="all">
              2017 French IPF guidelines [
              
              ]
             </para>
</list-item>
</list>
</td>
</tr>
</tbody>
</tgroup>
<legend>
<simple-para id="sp0045" view="all">
         DL
         <inf loc="post">
          CO
         </inf>
         Diffusing capacity of the lungs for carbon monoxide; IPF idiopathic pulmonary fibrosis.
        </simple-para>
</legend>
</table>
</html>
<!DOCTYPE html>
<html><head><style>table, th, td {border: 1px solid black;border-collapse: collapse;}</style></head>
<table colsep="0" frame="topbot" id="t0010" trsep="0" xmlns="http://www.elsevier.com/xml/common/cals/dtd">
<label>
        Table 2
       </label>
<caption id="ca0015">
<simple-para id="sp0030" view="all">
         ASMD observational and natural history studies of patients with chronic ASMD describing associations of DL
         <inf loc="post">
          CO
         </inf>
         or splenomegaly with morbidity, mortality or quality of life.
        </simple-para>
</caption>

<tgroup cols="5">
<colspec colname="col1"/>
<colspec colname="col2"/>
<colspec colname="col3"/>
<colspec colname="col4"/>
<colspec colname="col5"/>
<thead>
<tr trsep="1" valign="top">
<td colname="col1" xmlns="http://www.elsevier.com/xml/common/dtd">
           Study design
          </td>
<td colname="col2" xmlns="http://www.elsevier.com/xml/common/dtd">
           Relevant population
          </td>
<td colname="col3" xmlns="http://www.elsevier.com/xml/common/dtd">
           DL
           <inf loc="post">
            CO
           </inf>
           -related
          </td>
<td colname="col4" xmlns="http://www.elsevier.com/xml/common/dtd">
           Spleen-related
          </td>
<td colname="col5" xmlns="http://www.elsevier.com/xml/common/dtd">
           Reference
          </td>
</tr>
</thead>
<tbody>
<tr>
<td colname="col1" xmlns="http://www.elsevier.com/xml/common/dtd">
           Multicenter, multinational prospective, cross-sectional natural history study (US, Italy, Brazil, France and Germany)
          </td>
<td colname="col2" xmlns="http://www.elsevier.com/xml/common/dtd">
           59 pediatric or adult patients with chronic ASMD ranging in age from 7 to 65 years
          </td>
<td colname="col3" xmlns="http://www.elsevier.com/xml/common/dtd">
           Shortness of breath; disease severity
          </td>
<td colname="col4" xmlns="http://www.elsevier.com/xml/common/dtd">
           Bleeding/bruising, increased liver volume, atherogenic lipid profile, below average height z scores, hematologic abnormalites, lung parameters (including fibrosis scores, % predicted DLco, % predicted FVC)
          </td>
<td colname="col5" xmlns="http://www.elsevier.com/xml/common/dtd">
           McGovern et al. [
           
           ]
          </td>
</tr>
<tr>
<td colname="col1" xmlns="http://www.elsevier.com/xml/common/dtd">
           Retrospective and prospective natural history study (Belgium and the Netherlands)
          </td>
<td colname="col2" xmlns="http://www.elsevier.com/xml/common/dtd">
           25 pediatric or adult patients with chronic ASMD with up to 11 years of follow-up
          </td>
<td colname="col3" xmlns="http://www.elsevier.com/xml/common/dtd">
           6 min walk test; disease progression
          </td>
<td colname="col4" xmlns="http://www.elsevier.com/xml/common/dtd">
           No significant correlations between baseline spleen volume and platelets, lipids, DLco, bone martr fat burden, chitotriosidase
          </td>
<td colname="col5" xmlns="http://www.elsevier.com/xml/common/dtd">
           Hollack et al. [
           
           ]
          </td>
</tr>
<tr>
<td colname="col1" xmlns="http://www.elsevier.com/xml/common/dtd">
           Systematic evaluation of morbidity and mortality (US single center)
          </td>
<td colname="col2" xmlns="http://www.elsevier.com/xml/common/dtd">
           103 pediatric or adult patients with chronic ASMD ranging in age from 1 to 72 years
          </td>
<td colname="col3" xmlns="http://www.elsevier.com/xml/common/dtd">
           NR
          </td>
<td colname="col4" xmlns="http://www.elsevier.com/xml/common/dtd">
           Higher mortality in splenectomized patients
          </td>
<td colname="col5" xmlns="http://www.elsevier.com/xml/common/dtd">
           McGovern et al. [
           
           ]
          </td>
</tr>
<tr>
<td colname="col1" xmlns="http://www.elsevier.com/xml/common/dtd">
           Assessment of bone scans (US single center)
          </td>
<td colname="col2" xmlns="http://www.elsevier.com/xml/common/dtd">
           46 pediatric or adult patients with chronic ASMD ranging in age from 1.6 to 54.5 years
          </td>
<td colname="col3" xmlns="http://www.elsevier.com/xml/common/dtd">
           NR
          </td>
<td colname="col4" xmlns="http://www.elsevier.com/xml/common/dtd">
           Lumbar bone mineral density
           <italic>
            Z
           </italic>
           -score
          </td>
<td colname="col5" xmlns="http://www.elsevier.com/xml/common/dtd">
           Wasserstein et al. [
           
           ]
          </td>
</tr>
<tr>
<td colname="col1" xmlns="http://www.elsevier.com/xml/common/dtd">
           Cross-sectional anlysis of gtrth in children (US single center)
          </td>
<td colname="col2" xmlns="http://www.elsevier.com/xml/common/dtd">
           23 children and adolescents with chronic ASMD ranging in age from 3.7 to 18.3 years
          </td>
<td colname="col3" xmlns="http://www.elsevier.com/xml/common/dtd">
           NR
          </td>
<td colname="col4" xmlns="http://www.elsevier.com/xml/common/dtd">
           Short stature and low weight
          </td>
<td colname="col5" xmlns="http://www.elsevier.com/xml/common/dtd">
           Wasserstein et al. [
           
           ]
          </td>
</tr>
</tbody>
</tgroup>
<legend>
<simple-para id="sp0035" view="all">
         DL
         <inf loc="post">
          CO
         </inf>
         diffusing capacity of the lungs for carbon monoxide; FVC forced vital capacity; NR not reported.
        </simple-para>
</legend>
</table>
</html>
